MoneyWorks4Me

Biocon informs about press release

17 Oct 2022 Evaluate

Biocon has informed that it enclosed the press release titled ‘Biocon Biologics Out-Licenses Two Biosimilar Assets to Yoshindo for Commercialization in Japan’. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1782.00
Dr. Reddys Labs. 1208.00
Cipla 1334.00
Lupin 2010.00
Zydus Lifesciences 1138.50
View more..